Scar Pregnancy and Extrauterine Implants.

Area of Science:

• Reproductive Medicine
• Gynecologic Surgery
• Maternal-Fetal Medicine

Background:

• Cesarean scar pregnancy (CSP) involves embryo implantation in a prior cesarean delivery scar, posing risks like hemorrhage and uterine rupture.
• Ectopic pregnancy (EP), occurring in 1-2% of pregnancies, most commonly implants in the fallopian tube.
• Both conditions necessitate prompt diagnosis and intervention due to potential severe complications.

Purpose of the Study:

• To review the diagnosis and evolving treatment strategies for Cesarean scar pregnancy (CSP) and ectopic pregnancy (EP).
• To highlight the role of uterine artery embolization (UAE) as an adjuvant therapy in managing these high-risk pregnancies.

Main Methods:

• Diagnosis relies on patient history, clinical evaluation, serum β-human chorionic gonadotropin (β-hCG) levels, and ultrasonography.
• Treatment options include medical management (e.g., methotrexate), minimally invasive surgery, and uterine artery embolization (UAE).

Main Results:

• Uterine artery embolization (UAE) is increasingly utilized for hemorrhage control in CSP and EP.
• UAE is effective as an adjuvant treatment, particularly when combined with other therapeutic modalities.
• This approach aims to preserve uterine function while managing these complex pregnancy complications.

Conclusions:

• Early diagnosis and multidisciplinary treatment are critical for managing Cesarean scar pregnancy and ectopic pregnancy.
• Uterine artery embolization (UAE) is a valuable tool in the management of CSP and EP, offering a way to control bleeding and preserve the uterus.
• Further research into optimal treatment combinations may improve outcomes for women with these rare but serious conditions.